David E. Williams is President of the Health Business Group, a consulting firm that helps technology-enabled health care, medical device and pharmaceutical companies develop and execute innovative business strategies. He leads consulting teams, advises CEOs, is a member of corporate and non-profit boards, and chairs review panels for the federal government. He co-founded the company in 2003 after more than a decade as a consultant for the Boston Consulting Group and The LEK Partnership.
David has a rare ability to explain complex health care concepts simply and clearly, making him a sought after expert for media such as NPR, Business Week, Al Jazeera, US News and The Boston Globe. David produces the popular Health Business Blog, where he has written more than 4000 posts since 2005 and conducted more than 100 podcast interviews with entrepreneurs, executives, scientists and political leaders. During the Massachusetts gubernatorial race, he interviewed all nine candidates about health policy.
He is a board member of iCardiac Technologies (a leading core lab for clinical trials), Home Care Delivered (a medical supply company) and Clerio Vision (medical lasers). He chairs the advisory board for Medullan (digital healthcare laboratory). From 2006 to 2011 he served as chairman of online medical risk management and continuing medical education provider Advanced Practice Strategies, leading the company through an 8x increase in revenue and 30x increase in valuation in two rounds of financing. He is a former board member of Candescent Healing, the Center for the Evaluation of Value and Risk in Health, the Hearts & Noses Hospital Clown Troupe, and Boston Young Healthcare Professionals.
David has chaired and been a member of a variety of review panels for the Department of Health and Human Services as part of the Office of the National Coordinator for Health Information Technology’s Regional Extension Center (REC) program, which reviewed applications under the ARRA/HITECH Act. He also served on ONC review panels for the Beacon Community Cooperative Agreement Program and State Health Information Exchange Challenge Program and later chaired a panel to conduct a biennial review of the RECs. He also chaired a review panel for the Exchange Navigators under the Affordable Care Act.
David holds a BA in Economics from Wesleyan University, where he was elected to Phi Beta Kappa, and an MBA from Harvard Business School, with First Year Honors.
Patrick Kager is a co-founder of MedPharma Partners and the Health Business Group and has over 15 years of consulting experience working with pharmaceutical, biotechnology, medical device and health care organizations. Before his current role, he was a Partner in Deloitte Consulting’s Life Sciences practice. There he led creation of the firm’s pharmaceutical R&D and M&A market offerings while serving as lead client service partner for several top-10 pharmaceutical and biotech companies. Before Deloitte Consulting, Pat was a senior manager in the Boston Consulting Group’s health care practice.
Pat has successfully completed over 100 client engagements in the areas of corporate strategy, product development and commercialization strategy, R&D management, manufacturing and supply chain management, sales and marketing effectiveness, mergers and acquisitions, business process design and IT strategy. He has authored several articles for Harvard Business Review, Pharmaceutical Executive, and other journals examining topics of interest to the pharmaceutical and biotech industries and providing practical guidance to managers facing difficult business situations.
Pat holds a BS in electrical engineering and mathematics and an MS in computer engineering from Carnegie-Mellon University and earned an MBA with Distinction from Dartmouth’s Amos Tuck School of Business Administration.
Karen Donovan has held several senior strategic and operating roles at health care services, health care software, and consulting firms. She began her career more than 20 years ago at The LEK Partnership, where she led strategic development projects, M&A screenings, and competitive benchmarking for managed care, health care services, medical technology, and diagnostics clients. As Director of Strategic Development at VITAS Healthcare, she helped develop clinical, financial, and operating software systems and best practices for operations in 31 cities, spanning home health, long-term care, and hospital care settings. In addition, she led the development of a contract services subsidiary to provide these systems and services to outside companies. As VP of Operations at CareTools, an enterprise-wide health care software company, Karen oversaw customer sales and systems implementations for customer segments that included disease management companies, physician practice management, and MSO companies.
As an independent consultant, she provided strategic expertise to investment, health care services, health care IT, and pharmaceutical clients. At Health Business Group she has performed numerous market assessments and M&A evaluations in health care technology, services, and payer markets. She has extensive experience in strategic planning and sustainability assignments with non-profit and multi-stakeholder organizations.
Karen has a BS in Economics from the Wharton School of Business at the University of Pennsylvania, where she was on the Dean’s List. She is an active angel investor in early-stage healthcare companies and a board member for Bliss Healthcare, an integrated software and services solutions company serving healthcare providers.
Dan Segal was a co-founder of Brain Resource Ltd, an ASX/OTC listed neuroscience company, and was a Board member and its COO/CFO for the last 15 years. For the decade prior to that he was a Director in the Equities Research Department at Citigroup and was highly ranked as a telecommunications and technology sector analyst by many of the largest mutual funds.
Dan has operational experience managing the science commerce interface with the focus on all aspects of what is required to develop and market new healthcare products. This includes strategic plans, regulatory navigation, integration with user workflows, clinical trials, IT development, ISMS and GCP systems and contracting with academia, pharma and payers in the US and internationally. He also has experience in managing coporate and legal affairs as well as in IPOs and fund raising. His role as an equities analyst involved high degree of strategic industry and company analysis and financial modelling.
Dan has been a member of the Australian Institute of Chartered Accountants for 30 years and has qualifications in Science and Commerce (Bachelor of Commerce from the University of New South Wales, Bachelor of Science (Honours) from the University of Sydney and a Master of Science (Physics) from the University of New South Wales). Dan retains an active research interest in connections between physics and the brain and has authored both science and business articles, ranging from Personalized Medicine and digital health to semiconductor physics.
Amy M. Lischko, MSPH, D. Sc. has over twenty five years of health services research experience. She worked for the Commonwealth of Massachusetts in senior-level positions under the Weld, Swift and Romney administrations. Until 2007, Amy led a 100-person agency within the Office of Health and Human Services and was concurrently the health policy advisor to the secretary. She holds a doctorate degree in health services research from Boston University with a concentration in quality measurement. During her tenure with state government Amy oversaw various research and policy activities and she was one of the key authors of the administration’s health care reform legislation. She also led the state’s initial efforts in increasing the transparency of health care quality and cost information by establishing a consumer website.
Amy began a faculty position at Tufts University School of Medicine in July 2007 and is currently an Associate Professor of Public Health and Community Medicine. She has provided consulting services to numerous organizations and individual states around various aspects of health care reform and quality improvement. Amy’s research interests are focused on using data to develop strategies for constraining health care costs while improving quality. She is interested in bridging the gap between academic researchers and policymakers by making academic research more accessible to policymakers.
At Health Business Group, Amy focuses on economic analysis and growth strategies for health care providers and multi-stakeholder non-profit organizations.
Trevor McCaw is an experienced consultant, entrepreneur and Fortune 500 manager, with substantial expertise in health care services, information technology and medical devices. Before joining Health Business Group, Trevor worked in Minneapolis for Medtronic’s Patient Management Group where he focused on the planning and launch of CareLink, Medtronic’s industry-leading remote patient monitoring technology. He was responsible for adding a new class of devices to CareLink, which included establishing overall strategic/product planning objectives, working with the FDA on 510k approval, interfacing with CMS to establish reimbursement, training the salesforce, preparing market launch material and creating a customer support infrastructure. Trevor was named one of only 30 “Emerging Leaders” within the company by Medtronic’s executive management.
Prior to Medtronic Trevor worked as a consultant for the Boston Consulting Group and Innosight. As an entrepreneur, Trevor founded Sentinel Medical Technologies, a health care technology commercialization company, and co-founded an enterprise software company that went public in 2001 on the AIM stock exchange.
Trevor received a Bachelor of Electrical Engineering from Queen’s University in Canada and an MBA from Harvard Business School.
John Seus has 20 years of health care industry and consulting experience. He started his career in pharmaceutical R&D at Procter & Gamble. Later, John was a partner for eight years at A.T. Kearney and Deloitte Consulting.
John has led projects in strategy, operations and technology for clients in all sectors of the health care industry. He has extensive experience in assisting medical device companies with all aspects of strategy and commercial operations including market assessment, technology assessment, new product launch, pricing, marketing strategy, sales force structure and management and channel strategy. He has assisted clients in establishing value platforms for key products and technologies and bringing them to market including products in orthopedics, cardiology, minimally invasive surgery, transplantation and in-vitro diagnostics as well as computer operating systems and supply chain technologies.
He also has deep experience in operations improvement, benchmarking, cost reduction, outsourcing and functional strategy development in manufacturing and supply chain, R&D, finance and other back office functions for pharmaceutical, biopharmaceutical and medical device companies.
John holds a B.S. in chemical engineering from the University of Massachusetts at Amherst where he was ranked second in his class. He received his MBA from Harvard where he focused on finance and operations.
Mack Amaker has provided and directed business process and technical consulting services for more than 20 years. His primary areas of focus include health care services, pharmaceuticals, medical devices, logistics, and consumer goods. His expertise spans process and technical innovation, solution design and implementation.
Selected accomplishments include:
- Built and managed a 25-person information technology organization to support business operations for an international medical equipment company
- Directed a 60-person project to implement shared architecture, customer relationship and financial services to reduce operating costs by 15 to 20 percent for a major equipment manufacturer
- Integrated a new contract management system to provide more accurate and timely financial data and reduce capital costs for a major health insurer
- Developed the financial procurement and payment strategy and identified related web technologies to substantially reduce supplies, materials and internal operating costs for a major pharmaceutical company
- Designed the processes and web-based technologies for tracking capital projects globally to reduce total capital spend for a major pharmaceutical company
Mack is a Certified Public Accountant in New Jersey and Georgia. He has worked for major accounting and software firms.